# Alexandre Reuben

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alexandre-reuben/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,742 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 56 |
| i10-index | 106 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5088889988 |
| ORCID iD | https://orcid.org/0000-0003-4510-0382 |
| Works | 431 |

## Researcher papers

- [B cells and tertiary lymphoid structures promote immunotherapy response](https://scholariq.org/papers/b-cells-and-tertiary-lymphoid-structures-promote-immunotherapy-response/)
- [Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma](https://scholariq.org/papers/defining-t-cell-states-associated-with-response-to-checkpoint-immunotherapy-in/)
- [Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine](https://scholariq.org/papers/potential-role-of-intratumor-bacteria-in-mediating-tumor-resistance-to-the/)
- [Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma](https://scholariq.org/papers/neoadjuvant-immune-checkpoint-blockade-in-high-risk-resectable-melanoma/)
- [Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial](https://scholariq.org/papers/neoadjuvant-nivolumab-or-nivolumab-plus-ipilimumab-in-operable-non-small-cell/)
- [Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance](https://scholariq.org/papers/pan-cancer-t-cell-atlas-links-a-cellular-stress-response-state-to-immunotherapy/)
- [Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma](https://scholariq.org/papers/defining-t-cell-states-associated-with-response-to-checkpoint-immunotherapy-in-2/)
- [Immuno-genomic landscape of osteosarcoma](https://scholariq.org/papers/immuno-genomic-landscape-of-osteosarcoma/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.